Thinking of Buying a Next-Gen Sequencer? Consider These Tips From Early Users | GenomeWeb
Two post-Sanger sequencing technologies have reached the market so far, the third one will follow suit shortly, and an increasing number of potential users is thinking about acquiring one of the new instruments.
 
These tools promise to deliver hundreds of millions of DNA bases per run for a fraction of the cost of capillary electrophoresis sequencing, but what should users be aware of who are shopping for one?
 
As part of a pre-meeting workshop entitled “Utilization of New DNA Sequencing Technologies” at last week’s Advances

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.